Characterization of cancer stem cell properties of CD24 and CD26-positive human malignant mesothelioma cells.

[1]  A. Seth,et al.  IGFBP7 reduces breast tumor growth by induction of senescence and apoptosis pathways , 2012, Breast Cancer Research and Treatment.

[2]  C. Galet,et al.  IGFBP-3 is a metastasis suppression gene in prostate cancer. , 2011, Cancer research.

[3]  S. Iwata,et al.  Regulation of cancer stem cell properties by CD9 in human B-acute lymphoblastic leukemia. , 2011, Biochemical and biophysical research communications.

[4]  S. Iwata,et al.  Identification of cancer stem cell markers in human malignant mesothelioma cells. , 2011, Biochemical and biophysical research communications.

[5]  A. Yee,et al.  Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors , 2011, Breast Cancer Research and Treatment.

[6]  R. Schmid,et al.  Putative cancer stem cells in malignant pleural mesothelioma show resistance to cisplatin and pemetrexed. , 2010, International journal of oncology.

[7]  T. Haferlach,et al.  BAALC-associated gene expression profiles define IGFBP7 as a novel molecular marker in acute leukemia , 2010, Leukemia.

[8]  T. Yau,et al.  A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer. , 2010, Cell stem cell.

[9]  N. Cho,et al.  CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells , 2010, Oncogene.

[10]  M. Frank,et al.  The therapeutic promise of the cancer stem cell concept. , 2010, The Journal of clinical investigation.

[11]  S. Iwata,et al.  CD90 and CD110 correlate with cancer stem cell potentials in human T-acute lymphoblastic leukemia cells. , 2009, Biochemical and biophysical research communications.

[12]  S. Iwata,et al.  CD9 correlates with cancer stem cell potentials in human B-acute lymphoblastic leukemia cells. , 2009, Biochemical and biophysical research communications.

[13]  J. Visvader,et al.  Cancer stem cells in solid tumours: accumulating evidence and unresolved questions , 2008, Nature Reviews Cancer.

[14]  S. Hirohashi,et al.  Distinct gene expression-defined classes of gastrointestinal stromal tumor. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  Michael R. Green,et al.  Oncogenic BRAF Induces Senescence and Apoptosis through Pathways Mediated by the Secreted Protein IGFBP7 , 2008, Cell.

[16]  C. Morimoto,et al.  Stem cell properties and the side population cells as a target for interferon-alpha in adult T-cell leukemia/lymphoma. , 2007, Biochemical and biophysical research communications.

[17]  C. Morimoto,et al.  Humanized Anti-CD26 Monoclonal Antibody as a Treatment for Malignant Mesothelioma Tumors , 2007, Clinical Cancer Research.

[18]  P. Dalerba,et al.  Identification of pancreatic cancer stem cells. , 2006, Cancer research.

[19]  G. Bepler,et al.  Malignant pleural mesothelioma: a comprehensive review. , 2006, Cancer control : journal of the Moffitt Cancer Center.

[20]  J. Dick,et al.  Cancer stem cells: lessons from leukemia. , 2005, Trends in cell biology.

[21]  J. Corson.  Pathology of mesothelioma. , 2004, Thoracic surgery clinics.

[22]  Claude Denham,et al.  Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  S. Iwata,et al.  G1/S cell cycle arrest provoked in human T cells by antibody to CD26 , 2002, Immunology.

[24]  B. Mossman,et al.  Mesothelial cell transformation requires increased AP-1 binding activity and ERK-dependent Fra-1 expression. , 2002, Cancer research.

[25]  I. Weissman,et al.  Stem cells, cancer, and cancer stem cells , 2001, Nature.

[26]  G. Mills,et al.  In vitro and in vivo antitumor effect of the anti-CD26 monoclonal antibody 1F7 on human CD30+ anaplastic large cell T-cell lymphoma Karpas 299. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[27]  Chika Morimoto,et al.  The structure and function of CD26 in the T‐cell immune response , 1998, Immunological reviews.